Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet

NCT02993224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Transfusion-dependent Thalassemia
Non-transfusion-dependent Thalassemia

Interventions

DRUG: Deferasirox dispersable tablet (DT)
DRUG: Deferasirox film coated tablet (FCT)

Sponsor

Novartis Pharmaceuticals